Cite
HARVARD Citation
Saumoy, M. et al. (2017). Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy. HIV clinical trials. 18 (2), pp. 49-53. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Saumoy, M. et al. (2017). Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy. HIV clinical trials. 18 (2), pp. 49-53. [Online].